Learn more
In this section, you will learn more about Gattefossé Pharmaceuticals expertise, through news, hot topics and publications at the cutting edge of science, you can browse through a library of on-demands webinars, and download our latest brochures.
News and hot topics
Revolutionizing oral bioavailability: powdered lipid surfactants for tablets and capsules
Lipid-based excipients are widely recognized to improve API bioavailability by increasing solubility and permeability. Commonly liquid or waxy, they were primarily formulated in liquid dosage forms, whereas their use in oral solid dosage forms remained sporadic. Formulators often perceived lipid-based excipients as difficult to incorporate in their oral solid dosage forms manufacturing processes. Recent developments at Gattefossé opened the path for new powder surfactants, directly processable in tablets or hard capsules.
Lipid-Polymer Synergies: Enhancing Tablet Performance for New Drug Modalities
05 Jun 2026 Reading : 9mn
Discover how lipid excipients can enhance the performance of oral tablet formulations. Learn how common processing techniques such as spray drying and hot melt extrusion can be combined with lipid chemistries to boost drug exposure.
Webinars
When lipids go solid: process strategies to enhance bioavailability in oral dosage forms
Lipid excipients are known to improve the bioavailability of APIs by increasing their solubility and permeability. Generally liquid at room temperature, they are primarily formulated in liquid forms. Solid oral dosage forms (OSDs), such as tablets, can also benefit from the advantages of lipid excipients. This webinar highlights various processes for incorporating lipid excipients into tablets or powders intended for oral administration.
Long-acting veterinary medicines: Less stress, more success
Long acting veterinary formulations are generating growing interest due to their ability to improve therapeutic outcomes, enhance animal welfare, and increase treatment efficiency. This webinar provides key insights into developing sustained release formulations using Gattefossé excipients.
Latest Publications
Improving the Drug Loading Capacity and Downstream Processing of HPMCAS using Gelucire® 48/16 in Hot-Melt Extrusion
Jul 2026
This poster demonstrates how Gelucire® 48/16 enhances the hot-melt extrusion process, improves tabletability, and increases drug loading and release from HPMCAS-based amorphous solid dispersions.
Transcutol® V, a must-have, safe and versatile excipient for optimised veterinary medicines
Jul 2026
In this whitepaper, we focus on Transcutol® V, a powerful solvent, solubiliser and penetration enhancer, largely used across major animal species and in a variety of dosage forms. The main properties of Transcutol® V are described in comparison to other solvents used in veterinary medicines worldwide. Applications in oral, skin and injectable drug delivery are illustrated through market references and case studies elaborated in our Technical Centres of Excellence.
